MIR4478: A Drug Target / Disease Biomarker (G100616312)
MIR4478: A Drug Target / Disease Biomarker
MIR4478, also known as interleukin-48 (IL-48), is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and nervous system. It is a member of the IL-4 family of cytokines, which are a group of proteins that play a critical role in the regulation of immune and inflammatory responses.
One of the unique features of MIR4478 is its ability to induce the production of various cytokines and chemokines, including IL-12, IL-13, and IL-18. These cytokines are important for the recruitment of immune cells to the site of an infection or injury, as well as for the regulation of inflammation. MIR4478 has also been shown to play a role in the regulation of skin cell biology, including the production of skin-derived stem cells.
MIR4478 is also of interest as a potential drug target. The ability of MIR4478 to induce the production of cytokines and chemokines makes it a potential candidate for use in vaccines or therapeutic treatments that target these molecules. For example, MIR4478 has been shown to be effective in mouse models of skin cancer and has been shown to have anti-inflammatory effects.
In addition to its potential use as a drug target, MIR4478 is also of interest as a biomarker for the diagnosis and monitoring of various diseases. The production of IL-12 and other cytokines by MIR4478 can be used as a marker for the activity of immune cells, including T cells and natural killer cells. This makes MIR4478 an potential indicator of the immune response to an infection or injury.
In conclusion, MIR4478 is a protein that has the potential to be a drug target or biomarker. Its ability to induce the production of cytokines and chemokines makes it of interest for use in vaccines or therapeutic treatments. Additionally, its ability to be used as a marker for the immune response makes it a potential candidate for use in the diagnosis and monitoring of various diseases. Further research is needed to fully understand the potential of MIR4478 as a drug target or biomarker.
Protein Name: MicroRNA 4478
The "MIR4478 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4478 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664
